0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI-based Antibody Development Platform Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-32S17391
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global AI based Antibody Development Platform Market Research Report 2024
BUY CHAPTERS

Global AI-based Antibody Development Platform Market Research Report 2024

Code: QYRE-Auto-32S17391
Report
June 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI-based Antibody Development Platform Market

A critical aspect of a successful pandemic response is expedient antibody discovery, manufacturing and deployment of effective lifesaving treatments to patients around the world. However, typical drug discovery and development is a lengthy multi-step process that must align drug efficacy with multiple developability criteria and can take years to complete. In this context, artificial intelligence (AI), and especially machine learning (ML), have great potential to accelerate and improve the optimization of therapeutics, increasing their activity and safety as well as decreasing their development time and manufacturing costs. Artificial intelligence stands at the forefront of transforming antibody development. AI and machine learning (ML) algorithms can analyze vast datasets, uncover patterns, and predict outcomes with a speed and accuracy unattainable by human researchers.
The global AI-based Antibody Development Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for AI-based Antibody Development Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for AI-based Antibody Development Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for AI-based Antibody Development Platform in Pharmaceutical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of AI-based Antibody Development Platform include Kyinno Biotechnolog, XtalPi Inc, DenovAI Biotech, immunitoAI Private Limited, EVQLV, Creative Biolabs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for AI-based Antibody Development Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI-based Antibody Development Platform.
The AI-based Antibody Development Platform market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI-based Antibody Development Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI-based Antibody Development Platform companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI-based Antibody Development Platform Market Report

Report Metric Details
Report Name AI-based Antibody Development Platform Market
Segment by Type
  • Antibody Generation and Screening
  • Discovery and Target Recognition
  • Engineering and Optimization
  • Other
Segment by Application
  • Pharmaceutical
  • Biotechnology
  • Academic Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Kyinno Biotechnolog, XtalPi Inc, DenovAI Biotech, immunitoAI Private Limited, EVQLV, Creative Biolabs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI-based Antibody Development Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI-based Antibody Development Platform Market report?

Ans: The main players in the AI-based Antibody Development Platform Market are Kyinno Biotechnolog, XtalPi Inc, DenovAI Biotech, immunitoAI Private Limited, EVQLV, Creative Biolabs

What are the Application segmentation covered in the AI-based Antibody Development Platform Market report?

Ans: The Applications covered in the AI-based Antibody Development Platform Market report are Pharmaceutical, Biotechnology, Academic Research, Others

What are the Type segmentation covered in the AI-based Antibody Development Platform Market report?

Ans: The Types covered in the AI-based Antibody Development Platform Market report are Antibody Generation and Screening, Discovery and Target Recognition, Engineering and Optimization, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI-based Antibody Development Platform Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibody Generation and Screening
1.2.3 Discovery and Target Recognition
1.2.4 Engineering and Optimization
1.2.5 Other
1.3 Market by Application
1.3.1 Global AI-based Antibody Development Platform Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical
1.3.3 Biotechnology
1.3.4 Academic Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI-based Antibody Development Platform Market Perspective (2019-2030)
2.2 Global AI-based Antibody Development Platform Growth Trends by Region
2.2.1 Global AI-based Antibody Development Platform Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI-based Antibody Development Platform Historic Market Size by Region (2019-2024)
2.2.3 AI-based Antibody Development Platform Forecasted Market Size by Region (2025-2030)
2.3 AI-based Antibody Development Platform Market Dynamics
2.3.1 AI-based Antibody Development Platform Industry Trends
2.3.2 AI-based Antibody Development Platform Market Drivers
2.3.3 AI-based Antibody Development Platform Market Challenges
2.3.4 AI-based Antibody Development Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI-based Antibody Development Platform Players by Revenue
3.1.1 Global Top AI-based Antibody Development Platform Players by Revenue (2019-2024)
3.1.2 Global AI-based Antibody Development Platform Revenue Market Share by Players (2019-2024)
3.2 Global AI-based Antibody Development Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI-based Antibody Development Platform Revenue
3.4 Global AI-based Antibody Development Platform Market Concentration Ratio
3.4.1 Global AI-based Antibody Development Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI-based Antibody Development Platform Revenue in 2023
3.5 Global Key Players of AI-based Antibody Development Platform Head office and Area Served
3.6 Global Key Players of AI-based Antibody Development Platform, Product and Application
3.7 Global Key Players of AI-based Antibody Development Platform, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI-based Antibody Development Platform Breakdown Data by Type
4.1 Global AI-based Antibody Development Platform Historic Market Size by Type (2019-2024)
4.2 Global AI-based Antibody Development Platform Forecasted Market Size by Type (2025-2030)
5 AI-based Antibody Development Platform Breakdown Data by Application
5.1 Global AI-based Antibody Development Platform Historic Market Size by Application (2019-2024)
5.2 Global AI-based Antibody Development Platform Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI-based Antibody Development Platform Market Size (2019-2030)
6.2 North America AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI-based Antibody Development Platform Market Size by Country (2019-2024)
6.4 North America AI-based Antibody Development Platform Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI-based Antibody Development Platform Market Size (2019-2030)
7.2 Europe AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI-based Antibody Development Platform Market Size by Country (2019-2024)
7.4 Europe AI-based Antibody Development Platform Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI-based Antibody Development Platform Market Size (2019-2030)
8.2 Asia-Pacific AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI-based Antibody Development Platform Market Size by Region (2019-2024)
8.4 Asia-Pacific AI-based Antibody Development Platform Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI-based Antibody Development Platform Market Size (2019-2030)
9.2 Latin America AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI-based Antibody Development Platform Market Size by Country (2019-2024)
9.4 Latin America AI-based Antibody Development Platform Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI-based Antibody Development Platform Market Size (2019-2030)
10.2 Middle East & Africa AI-based Antibody Development Platform Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI-based Antibody Development Platform Market Size by Country (2019-2024)
10.4 Middle East & Africa AI-based Antibody Development Platform Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Kyinno Biotechnolog
11.1.1 Kyinno Biotechnolog Company Details
11.1.2 Kyinno Biotechnolog Business Overview
11.1.3 Kyinno Biotechnolog AI-based Antibody Development Platform Introduction
11.1.4 Kyinno Biotechnolog Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.1.5 Kyinno Biotechnolog Recent Development
11.2 XtalPi Inc
11.2.1 XtalPi Inc Company Details
11.2.2 XtalPi Inc Business Overview
11.2.3 XtalPi Inc AI-based Antibody Development Platform Introduction
11.2.4 XtalPi Inc Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.2.5 XtalPi Inc Recent Development
11.3 DenovAI Biotech
11.3.1 DenovAI Biotech Company Details
11.3.2 DenovAI Biotech Business Overview
11.3.3 DenovAI Biotech AI-based Antibody Development Platform Introduction
11.3.4 DenovAI Biotech Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.3.5 DenovAI Biotech Recent Development
11.4 immunitoAI Private Limited
11.4.1 immunitoAI Private Limited Company Details
11.4.2 immunitoAI Private Limited Business Overview
11.4.3 immunitoAI Private Limited AI-based Antibody Development Platform Introduction
11.4.4 immunitoAI Private Limited Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.4.5 immunitoAI Private Limited Recent Development
11.5 EVQLV
11.5.1 EVQLV Company Details
11.5.2 EVQLV Business Overview
11.5.3 EVQLV AI-based Antibody Development Platform Introduction
11.5.4 EVQLV Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.5.5 EVQLV Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs AI-based Antibody Development Platform Introduction
11.6.4 Creative Biolabs Revenue in AI-based Antibody Development Platform Business (2019-2024)
11.6.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI-based Antibody Development Platform Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Antibody Generation and Screening
 Table 3. Key Players of Discovery and Target Recognition
 Table 4. Key Players of Engineering and Optimization
 Table 5. Key Players of Other
 Table 6. Global AI-based Antibody Development Platform Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global AI-based Antibody Development Platform Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global AI-based Antibody Development Platform Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global AI-based Antibody Development Platform Market Share by Region (2019-2024)
 Table 10. Global AI-based Antibody Development Platform Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global AI-based Antibody Development Platform Market Share by Region (2025-2030)
 Table 12. AI-based Antibody Development Platform Market Trends
 Table 13. AI-based Antibody Development Platform Market Drivers
 Table 14. AI-based Antibody Development Platform Market Challenges
 Table 15. AI-based Antibody Development Platform Market Restraints
 Table 16. Global AI-based Antibody Development Platform Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global AI-based Antibody Development Platform Market Share by Players (2019-2024)
 Table 18. Global Top AI-based Antibody Development Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Antibody Development Platform as of 2023)
 Table 19. Ranking of Global Top AI-based Antibody Development Platform Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by AI-based Antibody Development Platform Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of AI-based Antibody Development Platform, Headquarters and Area Served
 Table 22. Global Key Players of AI-based Antibody Development Platform, Product and Application
 Table 23. Global Key Players of AI-based Antibody Development Platform, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global AI-based Antibody Development Platform Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global AI-based Antibody Development Platform Revenue Market Share by Type (2019-2024)
 Table 27. Global AI-based Antibody Development Platform Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global AI-based Antibody Development Platform Revenue Market Share by Type (2025-2030)
 Table 29. Global AI-based Antibody Development Platform Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global AI-based Antibody Development Platform Revenue Market Share by Application (2019-2024)
 Table 31. Global AI-based Antibody Development Platform Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global AI-based Antibody Development Platform Revenue Market Share by Application (2025-2030)
 Table 33. North America AI-based Antibody Development Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America AI-based Antibody Development Platform Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America AI-based Antibody Development Platform Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe AI-based Antibody Development Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe AI-based Antibody Development Platform Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe AI-based Antibody Development Platform Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific AI-based Antibody Development Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific AI-based Antibody Development Platform Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific AI-based Antibody Development Platform Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America AI-based Antibody Development Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America AI-based Antibody Development Platform Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America AI-based Antibody Development Platform Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa AI-based Antibody Development Platform Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa AI-based Antibody Development Platform Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa AI-based Antibody Development Platform Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Kyinno Biotechnolog Company Details
 Table 49. Kyinno Biotechnolog Business Overview
 Table 50. Kyinno Biotechnolog AI-based Antibody Development Platform Product
 Table 51. Kyinno Biotechnolog Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)
 Table 52. Kyinno Biotechnolog Recent Development
 Table 53. XtalPi Inc Company Details
 Table 54. XtalPi Inc Business Overview
 Table 55. XtalPi Inc AI-based Antibody Development Platform Product
 Table 56. XtalPi Inc Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)
 Table 57. XtalPi Inc Recent Development
 Table 58. DenovAI Biotech Company Details
 Table 59. DenovAI Biotech Business Overview
 Table 60. DenovAI Biotech AI-based Antibody Development Platform Product
 Table 61. DenovAI Biotech Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)
 Table 62. DenovAI Biotech Recent Development
 Table 63. immunitoAI Private Limited Company Details
 Table 64. immunitoAI Private Limited Business Overview
 Table 65. immunitoAI Private Limited AI-based Antibody Development Platform Product
 Table 66. immunitoAI Private Limited Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)
 Table 67. immunitoAI Private Limited Recent Development
 Table 68. EVQLV Company Details
 Table 69. EVQLV Business Overview
 Table 70. EVQLV AI-based Antibody Development Platform Product
 Table 71. EVQLV Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)
 Table 72. EVQLV Recent Development
 Table 73. Creative Biolabs Company Details
 Table 74. Creative Biolabs Business Overview
 Table 75. Creative Biolabs AI-based Antibody Development Platform Product
 Table 76. Creative Biolabs Revenue in AI-based Antibody Development Platform Business (2019-2024) & (US$ Million)
 Table 77. Creative Biolabs Recent Development
 Table 78. Research Programs/Design for This Report
 Table 79. Key Data Information from Secondary Sources
 Table 80. Key Data Information from Primary Sources
 Table 81. Authors List of This Report


List of Figures
 Figure 1. AI-based Antibody Development Platform Picture
 Figure 2. Global AI-based Antibody Development Platform Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global AI-based Antibody Development Platform Market Share by Type: 2023 VS 2030
 Figure 4. Antibody Generation and Screening Features
 Figure 5. Discovery and Target Recognition Features
 Figure 6. Engineering and Optimization Features
 Figure 7. Other Features
 Figure 8. Global AI-based Antibody Development Platform Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global AI-based Antibody Development Platform Market Share by Application: 2023 VS 2030
 Figure 10. Pharmaceutical Case Studies
 Figure 11. Biotechnology Case Studies
 Figure 12. Academic Research Case Studies
 Figure 13. Others Case Studies
 Figure 14. AI-based Antibody Development Platform Report Years Considered
 Figure 15. Global AI-based Antibody Development Platform Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 16. Global AI-based Antibody Development Platform Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global AI-based Antibody Development Platform Market Share by Region: 2023 VS 2030
 Figure 18. Global AI-based Antibody Development Platform Market Share by Players in 2023
 Figure 19. Global Top AI-based Antibody Development Platform Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Antibody Development Platform as of 2023)
 Figure 20. The Top 10 and 5 Players Market Share by AI-based Antibody Development Platform Revenue in 2023
 Figure 21. North America AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. North America AI-based Antibody Development Platform Market Share by Country (2019-2030)
 Figure 23. United States AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Canada AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Europe AI-based Antibody Development Platform Market Share by Country (2019-2030)
 Figure 27. Germany AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Asia-Pacific AI-based Antibody Development Platform Market Share by Region (2019-2030)
 Figure 35. China AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Japan AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. South Korea AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Southeast Asia AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. India AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Australia AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Latin America AI-based Antibody Development Platform Market Share by Country (2019-2030)
 Figure 43. Mexico AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Brazil AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East & Africa AI-based Antibody Development Platform Market Share by Country (2019-2030)
 Figure 47. Turkey AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. UAE AI-based Antibody Development Platform Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 50. Kyinno Biotechnolog Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)
 Figure 51. XtalPi Inc Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)
 Figure 52. DenovAI Biotech Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)
 Figure 53. immunitoAI Private Limited Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)
 Figure 54. EVQLV Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)
 Figure 55. Creative Biolabs Revenue Growth Rate in AI-based Antibody Development Platform Business (2019-2024)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart